Gotu Kola: Benefits for Skin, Wound Healing & Cognition — A Research-Backed Guide

What is gotu kola?

Centella asiatica, commonly called gotu kola, is a small, fan-leaved perennial herb that thrives in the wetlands and tropical forests of South and Southeast Asia. It has no relation to the cola nut and contains no caffeine. In Ayurvedic tradition it is called mandookaparni (frog leaf) and classified as a medhya rasayana — an herb that rejuvenates the mind and nervous system. Traditional Chinese medicine uses it as ji xue cao for clearing heat and resolving dampness.

Modern pharmacological interest began in the 1950s–1970s when French researchers isolated the plant's key triterpenoids and demonstrated their effects on fibroblasts and collagen in vitro. Today gotu kola is included in European and WHO monographs for venous insufficiency and wound care, giving it one of the stronger regulatory bases among herbal supplements.

Dietary sources are limited — gotu kola is consumed as a leafy vegetable in some South Asian cuisines, particularly in Sri Lanka and Indonesia. Supplement concentrations far exceed typical food amounts.

Active compounds: triterpenoids explained

The pharmacological activity of gotu kola is concentrated in its pentacyclic triterpenoid saponins, which fall into two structural classes:

• Asiaticoside — a glycoside of asiatic acid; stimulates collagen Type I synthesis, promotes fibroblast proliferation, and accelerates re-epithelialization. The most widely studied compound.
• Madecassoside — a glycoside of madecassic acid; strong anti-inflammatory and antioxidant properties; appears to inhibit hypertrophic scar formation.
• Asiatic acid and madecassic acid — the free aglycones released after gut hydrolysis; cross the blood-brain barrier better than their glycosides, which may explain the cognitive signals.

Quality standardized extracts specify their total triterpenoid content (typically 40%), the ratio of asiaticoside to madecassoside, or both. Unstandardized powders from dried leaf vary dramatically in potency and are not appropriate for therapeutic dosing.

Evidence-based benefits of gotu kola

1. Wound healing and skin repair

This is the strongest evidence domain for gotu kola. Multiple controlled trials and a European regulatory approval (EMA positive opinion for traditional use in minor wound healing) support the following mechanisms:

• Stimulation of fibroblast proliferation and collagen I/III synthesis in the dermis
• Acceleration of granulation tissue formation and wound contraction
• Reduction in post-surgical scar hypertrophy (keloid prevention)

A 2013 randomized trial (Somboonwong et al.) in healthy volunteers with standardized punch-biopsy wounds showed that oral Centella extract 60 mg twice daily for four weeks significantly increased collagen synthesis markers and tensile wound strength compared to placebo. Topical Centella preparations are widely used in burn and surgical wound care in Europe and Asia.

2. Chronic venous insufficiency (CVI)

Gotu kola is one of the better-studied herbals for CVI — the condition causing leg swelling, heaviness, and varicose veins from impaired venous return. A 2001 Cochrane-style meta-analysis by Pittler and Ernst found that TECA (the standardized triterpenoid extract, 60–120 mg/day for 4–8 weeks) significantly reduced ankle edema and patient-reported leg heaviness compared to placebo, with a number needed to treat in the range of 5–7 for symptom reduction. TECA is approved as a pharmaceutical in France for this indication.

3. Skin collagen density and anti-aging

Several double-blind trials show that oral gotu kola extract (500–1000 mg/day for 8–12 weeks) increases dermal collagen density measured by ultrasound and skin elasticity by extensiometry in women over 40. One notable study (Haftek et al., 1994, n=53) found a statistically significant improvement in skin firmness versus placebo at 12 weeks. These effects are consistent with the known mechanism but the trial sizes are small.

4. Cognitive function (modest signal)

Several short-duration trials — primarily in older adults and mild cognitive impairment populations — have shown that gotu kola extract modestly improves working memory, attention, and processing speed. A 2016 randomized trial (Wattanathorn et al., n=28 older adults) found that 500 mg and 750 mg/day of standardized Centella extract for two months improved scores on cognitive function assessments compared to placebo. The effect size is small and reproducibility across populations has not been established. Gotu kola is not a substitute for established cognitive interventions.

5. Anxiety (preliminary)

Animal models consistently show anxiolytic activity attributed to modulation of the GABA system by triterpenoids. One human crossover study (Bradwejn et al., 2000) found that a single 12 g dose of dried gotu kola leaf blunted the acoustic startle response (a physiological anxiety marker) compared to placebo. The clinical relevance of this dose and single-session design is limited. No multi-week human RCT for anxiety has been published as of this writing.

Supplement forms compared

How much gotu kola should you take?

There is no established RDA or Tolerable Upper Intake Level for gotu kola. Clinical and traditional-use recommendations:

• Skin and wound healing: 500 mg standardized extract (40% triterpenoids) twice daily with meals, for 4–12 weeks
• Venous insufficiency: 60–120 mg/day of TECA (equivalent to ~150–300 mg of 40% standardized extract), the dose used in European clinical trials
• Cognitive support: 500–750 mg/day standardized extract; evidence for higher doses is limited
• Traditional tea / whole herb: 1–2 g dried leaf in 150 mL water, 2–3 times daily — widely used in Ayurveda but difficult to standardize

Take with food to minimize GI upset. Limit continuous use to 8 weeks; take a 2-week break before resuming if longer use is desired, to reduce cumulative liver-enzyme load. Do not use indefinitely without periodic liver-enzyme monitoring.

Safety, side effects, and liver caution

At standard oral doses (500–1000 mg/day for up to 8 weeks), gotu kola is generally well tolerated. The most common adverse effects are mild and transient:

Common low-dose side effects

• Mild nausea and GI discomfort (take with food)
• Headache
• Drowsiness in sensitive individuals
• Contact dermatitis with topical preparations (rare sensitization to asiaticoside)

Liver (hepatotoxicity) warning

Multiple case reports of drug-induced liver injury (DILI) have been attributed to gotu kola supplements, including one that required liver transplantation. The mechanism is unclear — possibly idiosyncratic or pyrrolizidine-alkaloid contamination in adulterated products. People with any pre-existing liver disease (hepatitis, cirrhosis, elevated transaminases) should not take gotu kola. Healthy adults using short-term standard doses appear to have low absolute risk, but it is not zero. The WHO monograph lists hepatotoxicity as a known risk. Cease use and consult a physician immediately if jaundice, right upper quadrant pain, or fatigue develops.

Pregnancy and breastfeeding

Gotu kola demonstrated uterotonic activity (stimulation of uterine contractions) in animal models at elevated doses. Oral supplementation is contraindicated during pregnancy. Breastfeeding women should also avoid supplemental gotu kola due to the lack of human safety data in this population. Low-level topical exposure in cosmetic products is a lower-risk category, but erring on the side of caution is appropriate.

Drug and herb interactions

• Hepatotoxic drugs (acetaminophen at high doses, methotrexate, statins) — additive liver-stress risk; avoid combining without clinical monitoring.
• Sedatives and CNS depressants (benzodiazepines, barbiturates, alcohol) — gotu kola has mild sedative properties; additive CNS depression possible.
• Antidiabetic medications — preliminary in vitro data suggest Centella may lower blood glucose; theoretically additive with insulin or metformin; monitor blood sugar if combined.
• Anticoagulants / antiplatelet agents (warfarin, aspirin, clopidogrel) — weak antiplatelet activity noted in vitro; clinical significance is unestablished, but caution is appropriate.
• Cholesterol-lowering agents — one animal study showed gotu kola elevated cholesterol in diabetic models; clinical relevance unclear but worth noting if lipid management is a concern.

Check our free interaction checker for additional combinations.

Who might benefit — and who shouldn't bother

Frequently asked questions

Related ingredients and articles